JapanStake
Pharmaceutical · Fiscal year end Dec 31

TMS Co., Ltd

4891

㈱ティムス

FIGI BBG001CDXPK14891.T4891 JPCorp. no. 5013401006469

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-14

For the first half of the fiscal year to 2026-12: Ordinary income ¥-0.4 billion, Net income ¥-0.4 billion.

This periodYear on year
Ordinary profit−¥392m—
Net profit to owners−¥394m—

From the securities report on EDINET, which states no forecast. History via /v1/companies/4891/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2025-12-31
Revenue
—
Net income
−¥716m
ROE
-25.9%
Equity ratio
95.5%
Dividend / share
—
Employees
18
Revenue · ¥bn
FY2021: ¥1.9bn 1.95 FY2021FY2022FY2023FY2024FY2025
Net income · ¥bn
FY2021: ¥1.1bn 1.08 FY2021FY2022: −¥0.9bn -0.86 FY2022FY2023: −¥1.0bn -0.96 FY2023FY2024: −¥0.7bn -0.66 FY2024FY2025: −¥0.7bn -0.72 FY2025
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2025-12-31—−¥716m¥2,865m¥2,771m-25.9%¥-16.08−¥780m
2024-12-31—−¥661m¥3,032m¥2,815m-23.7%¥-16.38−¥494m
2023-12-31—−¥960m¥3,555m¥3,457m-26.8%¥-26.02−¥823m
2022-12-31—−¥861m¥3,790m¥3,714m-27.9%¥-25.28−¥688m
2021-12-31¥1,947m¥1,077m¥2,740m¥2,453m60.2%¥53.36¥1,262m

Indicators

Computed by us from filings · fiscal year to 2025-12-31
MetricValuePercentile among listed companies
ROE, %-25.92.1
Ordinary margin——
Equity ratio, %95.599.9
Revenue growth——
Net income growth-0.08429.1
Operating cash flow / assets-0.27221.9
Policy-uncertainty measure0.37 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Fiscal & tax 1 Regulation 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change −2.42pt in 90 days; 0.0% held by other listed companies.

Results wording balance: -1.00. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4891/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-03-30: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断した。 Filing

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥97¥357¥616 2022-11-222026-08-06 2026-08-06 · sold 412,600 @ ¥97 · グロース・キャピタル株式会社2024-01-31 · bought 3,659,487 @ ¥187 · RTW Investments, LP2022-11-22 · sold 73,300 @ ¥616.4 · ニッセイ・キャピタル株式会社2022-11-22 · sold 2,800 @ ¥616.4 · 三生キャピタル株式会社2022-11-22 · sold 26,800 @ ¥616.4 · JAICシードキャピタル株式会社2022-11-22 · sold 49,600 @ ¥616.4 · DCIパートナーズ株式会社
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
グロース・キャピタル株式会社2025-03-31 – 2026-08-06+2,425,400+5.01pt¥97¥97–97
東北大学ベンチャーパートナーズ株式会社2022-11-22 – 2026-03-10-1,126,000−2.49pt——
RTW Investments, LP2024-01-31 – 2025-09-040+0.69pt¥187¥187–187
三菱UFJキャピタル株式会社(組合名)三菱UFJキャピタル4号投資事業有限責任組合2024-06-05 – 2025-01-23-1,676,500−5.27pt——
auカブコム証券株式会社2023-03-28 – 2024-10-3100.00pt——
ニッセイ・キャピタル株式会社2022-11-22 – 2024-02-01-2,115,400−5.70pt¥616.4¥616–616
JAICシードキャピタル株式会社2022-11-22 – 2023-06-13-880,000−2.40pt¥616.4¥616–616
三生キャピタル株式会社2022-11-22 – 2023-05-26-240,000−0.67pt¥616.4¥616–616
DCIパートナーズ株式会社2022-11-22 – 2022-11-22-49,600−0.14pt¥616.4¥616–616

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4891/trades.

5% filings

Large shareholding reports on 4891
FiledFilerStakeChangeStated purpose
2026-11-04TOHOKU University Venture Partners3.85%−1.33ptpure investment
2026-08-14Growth Capital Inc.4.36%−1.09ptpure investment
2026-07-21Growth Capital Inc.5.45%−0.53ptpure investment
2026-06-30Growth Capital Inc.5.98%−1.20ptpure investment
2026-02-04TOHOKU University Venture Partners5.18%−1.08ptpure investment
2025-11-13TOHOKU University Venture Partners6.26%−1.61ptpure investment
2025-09-11RTW Investments, LP0.00%−9.09pt—
2025-06-18Growth Capital Inc.7.18%−0.41ptpure investment
2025-06-09Growth Capital Inc.7.59%−1.09ptpure investment
2025-05-30Growth Capital Inc.8.68%−1.19ptpure investment

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
— issues
Book value
—
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
1

Held by: CREEK & RIVER Co.,Ltd. 4763

Purposes, all holdings and mutual flags via /v1/companies/4891/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31
ShareholderSharesRatio
大和日台バイオベンチャー投資事業有限責任組合4,107,9209.03%
THVP-1号投資事業有限責任組合2,845,8606.25%
株式会社新日本科学1,433,3203.15%
楽天証券株式会社1,320,9002.90%
株式会社SBI証券1,268,4012.78%
individual holder975,0002.14%
individual holder804,0001.76%
individual holder700,0001.53%
ニッセイ・キャピタル9号投資事業有限責任組合664,3801.46%
individual holder539,8001.18%

Get this as JSON

GET /v1/companies/4891
GET /v1/companies/4891/financials
GET /v1/companies/4891/details
GET /v1/companies/4891/segments
GET /v1/companies/4891/voting
GET /v1/companies/4891/tender-offers
GET /v1/companies/4891/indicators
GET /v1/companies/4891/earnings-releases
GET /v1/events?ticker=4891
GET /v1/companies/4891/trades         
GET /v1/companies/4891/cross-holdings 
GET /v1/companies/4891/brief          

Plans from $9 a month · Documentation